Logo

Home

smallArrow

Stocks Screener

smallArrow

Ajanta Pharma

Ajanta Pharma Share Price

Ajanta Pharma (INR)3131.5-67   (-2.1%)

Exchange ScripsBSE532331NSEAJANTPHARMISININE031B01049

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Ajanta Pharma Performance

Market performance
Open price3238.75
High3238.75
Volumes119556
Prev Close3131.5
Low3117.85
Closing date2024-09-20
Historical performance
1 Year High3485.00
3 Year High3485.00
5 Year High3485.00
1 Year Low1650.05
3 Year Low1061.77
5 Year Low602.27

Ajanta Pharma Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
26310
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
48.31
Dividend Yield
Dividend Yield
0.81 %

Ajanta Pharma Investment Returns

1 Year
84%
3 Years
111.6%
5 Years
343.5%
10 Years
577%

Ajanta Pharma Technicals

IndicatorsValueSignal
5-DMA3153.19Bearish
10-DMA3259.63Bearish
20-DMA3215.76Bearish
50-DMA2897.66Bullish
100-DMA2623.62Bullish
200-DMA2371.32Bullish

Shareholding Pattern

FieldJun-2024Mar-2024Dec-2023Sep-2023Jun-2023
Promoters88888
Foreign Investors---------------
Domestic Investors88888
Public Investors7030855480543435626954866
Government1------------

Ajanta Pharma Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income8469861157260
Operating Profit1256588191045010245
Interest725810283
Depreciation1354130812531161
Profit Before Tax11139745290959002
Consolidated Net Profit8162588071276539
Adjusted EPS65475650

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital253253172174
Total Reserves35364336243246929777
Minority Interest------------
Total Non-Current Liabilities408177428502745
Total Liabilities45039470464196841090
Capital Work in Progress2565209515291082
Total Assets45039470464196841090

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities7851792156175763
Cash Flow from Investing Activities654-5596-741-2824
Cash Flow from Financing Activitie-10511-1082-4597-3183
Net Cash Inflow / Outflow-20061243279-244
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 48.31.
  • 3Y Stock Price CAGR of the stock is 29.2.
  • The stock has a beta of 0.2.
  • In the last financial year, the company had an EBITDA of ₹12565 Million.
  • The company generated revenue of ₹42087 Million in the previous financial year.

Ajanta Pharma

3131.5-67   (-2.1%)

Investment Amount: ₹ 172270
Current Value: ₹ 313150
Performence: 81.8%
P/L: ₹ 140880
Top Gainers
SymbolChange%
ITDCEM562.45(19%)
MARKSANS318.35(16%)
CONCORDBIO2601.1(16%)
MAGADSUGAR957.45(14%)
PRSMJOHNSN219.54(12%)
Top Losers
SymbolChange%
ROSSELLIND170.85(-73%)
SADHNANIQ59.21(-9%)
BHARATRAS11914.5(-7%)
PEARLPOLY42.08(-7%)
SAKSOFT276.15(-7%)
AGIIL1042.6(-6%)
GATECH1.17(-6%)
XTGLOBAL41.63(-6%)
Similar stocks

Panacea Biotec

▲ 62.2

314.09

August 20 - September 20

Concord Biotech

▲ 57.1

2601.1

August 20 - September 20

Marksans Pharma

▲ 44.3

318.35

August 20 - September 20

Syncom Formulations

▲ 39.5

22.71

August 20 - September 20

Wanbury

▲ 38.6

278.79

August 20 - September 20

Jubilant Pharmova

▲ 34.5

1206.1

August 20 - September 20

Brooks Laboratories

▲ 33.6

147.47

August 20 - September 20

Nectar Lifesciences

▲ 29.9

42.25

August 20 - September 20

Announcing Stock of the Month!

 

Phone

Registered Users

10 lacs

Google Rating

4.6